77 King St W, Suite 400, Toronto-Dominion Ctr, Toronto, ON
Year called to bar: 2000 (ON); 2000 (New York)
Jason Saltzman is a partner in the Corporate group at Dentons and co-leader of our national Mergers and Acquisitions group in Canada. Jason has deep expertise in mergers and acquisitions, as well as corporate and securities transactions. He has over 20 years of experience in cross-border M&A and corporate finance, including private investment in public equity (PIPE) transactions in various industries including the life sciences, energy, cannabis and mining sectors. Jason also supports public companies across all manner of corporate transactions, including M&A, initial public offerings, public and private offerings of equity and debt, proxy contests, and stock exchange listings. Prior to joining Dentons, Jason was a partner at a leading Canadian law firm in their Mergers & Acquisitions, Capital Markets, Private Equity and Mining practices. Prior to that, he practised cross-border mergers and acquisitions and securities with the Toronto office of a leading New York law firm.
On June 13, 2018, CentriLogic, a global provider of managed IT solutions, announced that it secured a significant equity investment from TriSpan Opportunities Fund and Long Point Capital. Financial terms of the investment were not disclosed.
On May 2, 2018, Aurora Cannabis completed its $1.23 billion (US$950 million) takeover bid for all of the outstanding shares CanniMed Therapeutics Inc. This transaction represents the largest to date (completed) acquisition for the Canadian cannabis sector.
On April 3, 2017, Stone Canyon Industries, LLC (SCI) announced the successful closing of its previously announced purchase agreement to acquire Mauser Group N.V. (Mauser), a global supplier of rigid packaging products and services for industrial use, from Clayton, Dubilier & Rice (CD&R), through its subsidiary BWAY Corp. (BWAY), a leading North American manufacturer of rigid metal and plastic containers.
Sunovion Pharmaceuticals Inc. (“Sunovion”) completed the acquisition of Cynapsus Therapeutics Inc. (“Cynapsus”) by way of plan of arrangement for approximately $841 million. The acquisition is aligned with Sunovion’s global strategy to expand and diversify its portfolio in key therapeutic areas, including neurology.
On June 23, 2015, Cynapsus Therapeutics Inc. completed its underwritten public offering in the United States of common shares at US$14.00 per share, for total gross proceeds of approximately US$72.5 million through a syndicate of underwriters led by Bank of America Merrill Lynch that included Nomura and Noble Life Science Partners. The offering was the first ever southbound-only underwritten equity offering under the MJDS and the issuer’s initial public offering in the US.
On June 18, 2015, Energy Fuels. (Energy Fuels) completed the acquisition of Uranerz Energy Corporation (Uranerz) in a merger transaction valued at approximately $135 million. The transaction was a unique and complex cross-border transaction involving the acquisition of a US public corporation (Uranerz) by a Canadian public company (Energy Fuels), with both companies being listed on the TSX and the NYSE MKT stock exchanges.
The Polynt Group, newly acquired CCP Composites, and certain of their subsidiaries (collectively, the Polynt/CCP Group), entered into senior secured US, Canadian, UK and Australian asset-based revolving credit facilities in the aggregate principal amount of US$100 million. The global facility is agented by Wells Fargo Bank, National Association.